You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Tumor protein 53 wild-type

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Endometrial Cancer Trial in Israel, United States (Selinexor, Matching Placebo for selinexor)

Recruiting
  • Endometrial Cancer
  • Miami Beach, Florida
  • +6 more
Jan 31, 2023

Solid Tumor Trial in United States (ASTX295)

Recruiting
  • Solid Tumor
  • Duarte, California
  • +9 more
Nov 18, 2022

Childhood Astrocytoma, Childhood Atypical Teratoid/Rhabdoid Tumor, Diffuse Intrinsic Pontine Glioma Trial in Rochester

Active, not recruiting
  • Childhood Astrocytoma
  • +9 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic
Sep 8, 2022

Advanced Soft-tissue Sarcoma, Metastatic Soft-tissue Sarcoma Trial in France (Pazopanib, HDM201)

Recruiting
  • Advanced Soft-tissue Sarcoma
  • Metastatic Soft-tissue Sarcoma
  • Bordeaux, France
  • +4 more
May 5, 2022

Oncogenetic Panel and Integrated Clinical Data Registry Study

Recruiting
  • Gastrointestinal Stromal Tumor (GIST)
    • Changhua, Taiwan
    • +12 more
    Dec 6, 2022

    Anemia, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Atlanta, Columbus, Salt Lake City (drug, other,

    Active, not recruiting
    • Anemia
    • +2 more
    • Atlanta, Georgia
    • +2 more
    Jan 28, 2023

    Solid Tumor, KRAS Mutation Trial (BI 3706674)

    Not yet recruiting
    • Solid Tumor, KRAS Mutation
    • BI 3706674
    • (no location specified)
    Sep 29, 2023

    Malignant Salivary Gland Cancer, Salivary Gland Cancer Trial in Tampa, Chicago, Ann Arbor (APG-115, Carboplatin)

    Recruiting
    • Malignant Salivary Gland Cancer
    • Salivary Gland Cancer
    • Tampa, Florida
    • +2 more
    Feb 10, 2022

    Solid Tumor, Lymphoma, Peripheral T-Cell Lymphoma Trial in United States (ALRN-6924)

    Completed
    • Solid Tumor
    • +2 more
    • Birmingham, Alabama
    • +12 more
    Jul 13, 2020

    Pancreatic Tumors, Solid Tumors, Biliary Tract Cancer Trial (BI 907828)

    Not yet recruiting
    • Pancreatic Neoplasms
    • +2 more
    • BI 907828
    • (no location specified)
    Aug 22, 2022

    Colorectal Cancer Trial in United States (Cetuximab, Neratinib)

    Withdrawn
    • Colorectal Cancer
    • Gainesville, Florida
    • +11 more
    Oct 26, 2021

    Solid Tumor With p53 Wild Type Status Trial in Worldwide (CGM097)

    Completed
    • Solid Tumor With p53 Wild Type Status
    • Boston, Massachusetts
    • +4 more
    Jun 10, 2021

    Patient-Derived Organoids and Clinical Response in Colon Cancer

    Recruiting
    • Colon Cancer
    • +2 more
    • Tumor biopsy
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Aug 11, 2021

    HLA-A2 Positive Cells Present, Refractory Melanoma Trial in Buffalo (Alpha-type-1 Polarized Dendritic Cells, Celecoxib, PD-1

    Recruiting
    • HLA-A2 Positive Cells Present
    • Refractory Melanoma
    • Alpha-type-1 Polarized Dendritic Cells
    • +5 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    Dec 12, 2022

    Lung Adenocarcinoma Trial in ZhengZhou (CIK, chemo)

    Terminated
    • Lung Adenocarcinoma
    • ZhengZhou, Henan, China
      Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
    May 10, 2021

    Advanced Solid and Hematological TP53wt Tumors Trial in Worldwide (HDM201, ancillary treatment)

    Completed
    • Advanced Solid and Hematological TP53wt Tumors
    • Boston, Massachusetts
    • +14 more
    May 20, 2021

    Colorectal Adenocarcinoma, RAS Wild Type, Stage IV Colorectal Cancer AJCC v7 Trial in United States (biological, drug, other)

    Completed
    Has Results
    • Colorectal Adenocarcinoma
    • +4 more
    • Bevacizumab
    • +4 more
    • Scottsdale, Arizona
    • +12 more
    Jan 27, 2022

    Initial Radiological Diagnosis Eligible for Tumor Resection, Initial Radiological Diagnosis Compatible With Newly Diagnosed

    Recruiting
    • Initial Radiological Diagnosis Eligible for Tumor Resection
    • +2 more
    • SonoCloud-9 (SC9) device
    • Temozolomide according Stupp protocol
    • Leuven, Belgium
    • +6 more
    Mar 28, 2022

    Recurrent Glioblastoma, IDH-Wildtype, Recurrent WHO Grade 2 Glioma, Recurrent WHO Grade 3 Glioma Trial (Biospecimen Collection,

    Not yet recruiting
    • Recurrent Glioblastoma, IDH-Wildtype
    • +2 more
    • Biospecimen Collection
    • +2 more
    • (no location specified)
    May 13, 2023

    Tumor Trial in Houston (SGT-53, Topotecan, Cyclophosphamide)

    Suspended
    • Neoplasm
    • SGT-53
    • +2 more
    • Houston, Texas
      Texas Children's Hospital
    Feb 7, 2022

    Resectable Soft Tissue Sarcoma, Soft Tissue Sarcoma Trial in United States (Navtemadlin, Radiation Therapy)

    Recruiting
    • Resectable Soft Tissue Sarcoma
    • Soft Tissue Sarcoma
    • Goodyear, Arizona
    • +52 more
    Jul 21, 2022

    Polyneuropathy, Amyloidosis Trial in Jette (ECG + echocardiography, Answering questionnaires)

    Recruiting
    • Polyneuropathy
    • Amyloidosis
    • ECG + echocardiography
    • Answering questionnaires
    • Jette, Belgium Capital City, Belgium
      UZ Brussel
    Jul 14, 2023

    Advanced BRAFV600 Wild-type Melanoma Trial in Worldwide (Cobimetinib, Atezolizumab, Pembrolizumab)

    Terminated
    Has Results
    • Advanced BRAFV600 Wild-type Melanoma
    • Tucson, Arizona
    • +120 more
    Aug 24, 2022

    Metastatic Pancreatic Cancer Trial in Dallas (SGT-53, nab-paclitaxel, Gemcitabine)

    Recruiting
    • Metastatic Pancreatic Cancer
    • SGT-53
    • +2 more
    • Dallas, Texas
      Mary Crowley Cancer Research Center
    Feb 7, 2022

    Metastatic Colorectal Cancer Trial (Cetuximab and irinotecan)

    Not yet recruiting
    • Metastatic Colorectal Cancer
    • Cetuximab and irinotecan
    • (no location specified)
    Jul 26, 2023